Pistachio (Pis v 3) IgE

If you have reacted to pistachio or cashew, knowing which exact proteins your immune system targets can sharpen your understanding of what set things off and how risky future exposures might be. This test looks for antibodies to one specific pistachio storage protein, called Pis v 3.

Pis v 3 is considered a minor pistachio allergen. Its main interest comes from a different angle: it resembles a storage protein in cashew, contributing to the overlap that helps explain why cashew and pistachio reactions so often travel together (though the strongest immunologic driver of this co-allergy is a different pair of proteins, Pis v 1 and Ana o 3).

What This Antibody Targets

IgE (immunoglobulin E) is the antibody class your immune system produces when it tags something as a threat that should set off an allergic reaction. Pis v 3 IgE refers specifically to the IgE antibodies your body has made against Pis v 3, a 7S globulin (a type of seed storage protein) found in pistachio. Pis v 3 is one of several officially recognized pistachio allergens, alongside Pis v 1, Pis v 2, Pis v 4, and Pis v 5.

A detectable level in your blood means your immune system has been sensitized to this particular protein. Sensitization is not the same as a clinical allergy. People can carry IgE to a food protein and still tolerate that food in real life. The reverse is also true: some people with convincing reactions have low or undetectable specific IgE.

Pistachio Allergy and Anaphylaxis

Pistachio allergy is an IgE-driven food allergy that can range from itching and hives to body-wide reactions including anaphylaxis (a severe, multi-organ allergic emergency). Seed storage proteins (the 2S albumins, 7S globulins, and 11S globulins) are the most concerning class of allergens, because antibodies against them are associated with serious, systemic reactions rather than mild oral symptoms alone.

In pistachio-allergic patients, IgE against recombinant Pis v 3 has been detected in a subset of cases in published series, marking it as a minor rather than dominant allergen. The major pistachio markers are Pis v 1 (a 2S albumin) and Pis v 2 (an 11S globulin), which carry more weight in predicting whether real-world pistachio exposure will cause a clinical reaction.

The Cashew Connection

Pis v 3 resembles a cashew protein called Ana o 1. Both belong to the same family of 7S vicilin storage proteins, and they share enough structural similarity that antibodies made against one can recognize the other. This vicilin cross-reactivity contributes to why cashew and pistachio allergies travel together, but the primary immunologic driver of the co-allergy is the 2S albumin pair Pis v 1 and Ana o 3.

When tested as part of a broader component panel in pediatric nut-allergic cohorts, the strongest predictors of clinical pistachio reactivity were Pis v 1 and the cashew protein Ana o 3, not Pis v 3 alone. The majority of children who reacted clinically to pistachio or cashew had detectable IgE to either Pis v 1 or Ana o 3, and higher Pis v 1 levels were the strongest single predictor of pistachio reactivity in these studies.

Where Pis v 3 Fits in the Allergy Workup

Pis v 3 IgE is best understood as one piece of a broader profile, not a standalone diagnostic test. Component-resolved diagnostics are panels that test IgE against individual allergen proteins rather than the whole nut. They are designed to sort out whether a positive whole-pistachio IgE result reflects true pistachio allergy, cross-reactivity from another nut, or harmless sensitization.

A detectable Pis v 3 result indicates sensitization to a vicilin-family storage protein that also exists in cashew. By itself, it does not confirm clinical pistachio allergy, does not rule it out, and does not establish severity. It contributes context, especially when paired with Pis v 1, Pis v 2, and cashew components such as Ana o 3.

When Results Can Be Misleading

• Sensitization without symptoms is common: detectable IgE (immunoglobulin E) to a food protein does not mean you will react when you eat that food.
• Low or undetectable IgE does not exclude allergy: some people with convincing pistachio reactions have negative or near-negative tests.
• Cross-reactivity blurs interpretation: because Pis v 3 resembles cashew Ana o 1, a positive result could reflect primary cashew sensitization with secondary recognition of pistachio rather than the other way around.
• Single-component testing is not the full picture: Pis v 3 is a minor allergen, so most clinical decisions rely on history combined with major components and, when needed, a supervised oral food challenge.

Tracking Your Trend

Specific IgE levels are not fixed numbers. They drift over time, can rise after exposures, and can fall as childhood food allergies resolve. For pistachio, as with most food allergies, watching the trajectory matters more than any single value. Pis v 3 itself has no established clinical cutpoint, so the trend over time is the most useful framing.

A reasonable approach if you are already known to react to pistachio or cashew is to retest annually, or sooner if your reaction history changes, you start an immunotherapy program, or you are weighing a supervised food challenge. Treat the first number as a baseline. The shape of the trend over years tells you whether your sensitization is rising, stable, or fading.

Decision Pathway for Out-of-Pattern Results

A positive Pis v 3 IgE result should prompt a few next steps rather than action on the number alone. The first move is to look at the rest of the pistachio and cashew component profile. Pis v 1 and Ana o 3 carry more weight for predicting real-world reactions, and their pattern alongside Pis v 3 helps clarify whether your immune system is recognizing pistachio specifically or reading pistachio because of a primary cashew sensitization.

If your component pattern combines with a reaction history or with elevated whole-pistachio or whole-cashew IgE, a board-certified allergist is the logical next stop. They can run a skin prick test, decide whether a supervised oral food challenge is appropriate, and prescribe an epinephrine auto-injector if clinical allergy is confirmed. Component results alone, without expert interpretation and clinical context, should not be the sole basis for either liberalizing or restricting your diet.